PATIENT REGISTRY SOFTWARE MARKET ANALYSIS

Patient Registry Software Market, By Type (Public Domain Registry Software, Commercial Registry Software), By Disease Area (Diabetes Registry, Cardiovascular Registry, Cancer Registry, Rare Disease/Orphan Disease Registry, Other Chronic Disease Registry), By End User (Government, Commercial), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Apr 2020
Code : CMI2055
Pages :165
Formats :
Excel and PDF
Industry : Healthcare IT

Patient Registry Software MarketSize and Trends

The global patient registry software market is estimated to account for US$ 1,540.9 Mn in terms of value in 2020, and is expected to reach US$ 3,116.9 Mn by the end of 2027.

North America held dominant position in the global patient registry software market in 2019, accounting for 45.8% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1. Global Patient Registry Software Market Share (%) Value, by Region, 2019

The global patient registry software market was valued at US$ 1,390.5 Mn in 2019 and is forecast to reach a value of US$ 3,116.9 Mn by 2027 at a CAGR of 10.6% between 2020 and 2027.

Figure 2. Global Patient Registry Software Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

In Europe, increasing prevalence of diabetes is expected to boost demand for PRS. For instance, according to Diabetes UK, over five million people will suffer from diabetes in the U.K. by 2025.

Increasing adoption of mHealth services such as monitoring services, diagnostic services, preventive services, treatment services, research processes, emergency response services, and doctor assistance services, is also expected to aid in growth of the market.